Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pericytes | 10 | 2024 | 298 | 3.700 |
Why?
|
Hypertension, Pulmonary | 17 | 2024 | 1604 | 3.000 |
Why?
|
Endothelial Cells | 15 | 2024 | 3581 | 1.170 |
Why?
|
Myocytes, Smooth Muscle | 4 | 2024 | 701 | 0.790 |
Why?
|
Pulmonary Artery | 7 | 2021 | 1938 | 0.720 |
Why?
|
Lung | 11 | 2024 | 10067 | 0.640 |
Why?
|
Chemokine CXCL12 | 1 | 2020 | 457 | 0.600 |
Why?
|
Neovascularization, Pathologic | 4 | 2019 | 2631 | 0.580 |
Why?
|
Education, Graduate | 1 | 2016 | 75 | 0.510 |
Why?
|
Cell Polarity | 2 | 2019 | 637 | 0.500 |
Why?
|
Writing | 1 | 2016 | 200 | 0.460 |
Why?
|
Cell Movement | 6 | 2019 | 5199 | 0.410 |
Why?
|
Wnt Proteins | 2 | 2016 | 722 | 0.380 |
Why?
|
Lung Diseases | 1 | 2021 | 1941 | 0.360 |
Why?
|
Guidelines as Topic | 1 | 2016 | 1394 | 0.330 |
Why?
|
Gene Knockdown Techniques | 3 | 2020 | 1604 | 0.310 |
Why?
|
MicroRNAs | 3 | 2013 | 3792 | 0.300 |
Why?
|
Fellowships and Scholarships | 1 | 2016 | 1134 | 0.280 |
Why?
|
Hepatitis B | 1 | 2012 | 709 | 0.270 |
Why?
|
Animals | 29 | 2024 | 168930 | 0.260 |
Why?
|
Mice | 19 | 2024 | 81889 | 0.240 |
Why?
|
Muscle, Smooth, Vascular | 4 | 2016 | 1494 | 0.240 |
Why?
|
Leukemia Inhibitory Factor | 1 | 2024 | 81 | 0.230 |
Why?
|
Pipecolic Acids | 1 | 2023 | 77 | 0.220 |
Why?
|
Neurogenic Inflammation | 1 | 2023 | 34 | 0.210 |
Why?
|
Coculture Techniques | 2 | 2019 | 1337 | 0.210 |
Why?
|
Interleukin-13 | 1 | 2024 | 391 | 0.200 |
Why?
|
beta Catenin | 4 | 2016 | 1048 | 0.200 |
Why?
|
Neurons, Afferent | 1 | 2023 | 498 | 0.180 |
Why?
|
Antithrombins | 1 | 2023 | 294 | 0.180 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2024 | 637 | 0.180 |
Why?
|
DNA Nucleotidylexotransferase | 1 | 2020 | 64 | 0.180 |
Why?
|
Arginine | 1 | 2023 | 932 | 0.170 |
Why?
|
Pneumonectomy | 2 | 2023 | 1147 | 0.170 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2012 | 2326 | 0.160 |
Why?
|
Benzylamines | 1 | 2020 | 251 | 0.160 |
Why?
|
Gene Products, nef | 1 | 2019 | 101 | 0.160 |
Why?
|
Heterocyclic Compounds | 1 | 2020 | 245 | 0.160 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2024 | 520 | 0.160 |
Why?
|
Mice, SCID | 2 | 2014 | 2628 | 0.150 |
Why?
|
Trachea | 2 | 2015 | 1094 | 0.150 |
Why?
|
Stomatitis, Aphthous | 1 | 2018 | 51 | 0.150 |
Why?
|
Mammals | 1 | 2023 | 1133 | 0.150 |
Why?
|
Bleomycin | 1 | 2019 | 492 | 0.150 |
Why?
|
Bacterial Toxins | 1 | 2023 | 922 | 0.150 |
Why?
|
Recombinant Proteins | 4 | 2023 | 6507 | 0.150 |
Why?
|
Cells, Cultured | 10 | 2019 | 18984 | 0.150 |
Why?
|
Paracrine Communication | 1 | 2019 | 277 | 0.140 |
Why?
|
Vasoconstriction | 1 | 2020 | 592 | 0.140 |
Why?
|
Interferon-alpha | 1 | 2021 | 910 | 0.140 |
Why?
|
Disease Models, Animal | 4 | 2023 | 18330 | 0.140 |
Why?
|
Bone Morphogenetic Protein Receptors, Type II | 2 | 2014 | 72 | 0.140 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2018 | 103 | 0.140 |
Why?
|
Carboxylic Ester Hydrolases | 1 | 2017 | 99 | 0.140 |
Why?
|
Proteoglycans | 1 | 2020 | 806 | 0.140 |
Why?
|
Signal Transduction | 8 | 2024 | 23619 | 0.130 |
Why?
|
Microvessels | 3 | 2017 | 586 | 0.130 |
Why?
|
Cell Hypoxia | 1 | 2019 | 661 | 0.130 |
Why?
|
Specimen Handling | 1 | 2021 | 706 | 0.130 |
Why?
|
Heparin | 1 | 2023 | 1636 | 0.130 |
Why?
|
Muscle Contraction | 1 | 2021 | 1208 | 0.130 |
Why?
|
Liver Neoplasms | 1 | 2012 | 4353 | 0.130 |
Why?
|
Fluorescent Antibody Technique | 2 | 2019 | 2470 | 0.130 |
Why?
|
Receptors, CXCR4 | 1 | 2020 | 729 | 0.120 |
Why?
|
Elafin | 1 | 2015 | 29 | 0.120 |
Why?
|
Methamphetamine | 1 | 2017 | 167 | 0.120 |
Why?
|
Homeodomain Proteins | 1 | 2024 | 2430 | 0.120 |
Why?
|
Pulmonary Circulation | 1 | 2018 | 744 | 0.120 |
Why?
|
Pulmonary Fibrosis | 1 | 2019 | 505 | 0.120 |
Why?
|
Humans | 31 | 2024 | 766766 | 0.120 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 1996 | 0.120 |
Why?
|
Heparan Sulfate Proteoglycans | 1 | 2015 | 111 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2016 | 254 | 0.120 |
Why?
|
Neovascularization, Physiologic | 3 | 2016 | 1368 | 0.120 |
Why?
|
Antigens | 1 | 2020 | 1441 | 0.120 |
Why?
|
Frizzled Receptors | 1 | 2014 | 86 | 0.120 |
Why?
|
Exosomes | 1 | 2019 | 417 | 0.120 |
Why?
|
Fibroblasts | 1 | 2024 | 4166 | 0.110 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2014 | 187 | 0.110 |
Why?
|
Sulfonamides | 1 | 2023 | 1982 | 0.110 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2016 | 414 | 0.110 |
Why?
|
Interleukin-10 | 1 | 2019 | 1182 | 0.110 |
Why?
|
Mice, Transgenic | 4 | 2020 | 9547 | 0.110 |
Why?
|
3' Untranslated Regions | 2 | 2013 | 515 | 0.110 |
Why?
|
Hydrogels | 1 | 2019 | 729 | 0.110 |
Why?
|
Atherosclerosis | 2 | 2023 | 3420 | 0.110 |
Why?
|
Integrin alpha3 | 1 | 2012 | 26 | 0.100 |
Why?
|
Microcirculation | 2 | 2015 | 1282 | 0.100 |
Why?
|
Receptor, TIE-2 | 1 | 2013 | 183 | 0.100 |
Why?
|
PPAR gamma | 1 | 2016 | 484 | 0.100 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2013 | 156 | 0.100 |
Why?
|
Leukotrienes | 1 | 2014 | 232 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2024 | 1882 | 0.100 |
Why?
|
Cell Division | 1 | 2020 | 4474 | 0.100 |
Why?
|
Cyclosporine | 1 | 2015 | 778 | 0.100 |
Why?
|
Cell Transdifferentiation | 1 | 2013 | 186 | 0.100 |
Why?
|
Aspergillus fumigatus | 1 | 2013 | 158 | 0.100 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 2012 | 151 | 0.100 |
Why?
|
Blotting, Western | 2 | 2016 | 5022 | 0.100 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2013 | 304 | 0.100 |
Why?
|
Magnetics | 1 | 2014 | 586 | 0.100 |
Why?
|
Precancerous Conditions | 1 | 2018 | 980 | 0.090 |
Why?
|
Cell Lineage | 1 | 2020 | 2572 | 0.090 |
Why?
|
Drug Design | 1 | 2016 | 1042 | 0.090 |
Why?
|
Drug Synergism | 1 | 2015 | 1756 | 0.090 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2012 | 219 | 0.090 |
Why?
|
Mice, Inbred C57BL | 6 | 2023 | 22352 | 0.090 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 627 | 0.080 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1646 | 0.080 |
Why?
|
Muscle Proteins | 1 | 2014 | 1160 | 0.080 |
Why?
|
Drug Discovery | 1 | 2016 | 1065 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3796 | 0.070 |
Why?
|
Osteoblasts | 1 | 2013 | 1144 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2014 | 1621 | 0.070 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2014 | 1245 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6066 | 0.070 |
Why?
|
Cell Differentiation | 1 | 2024 | 11651 | 0.070 |
Why?
|
Cytokines | 1 | 2021 | 7438 | 0.070 |
Why?
|
PTEN Phosphohydrolase | 1 | 2012 | 1117 | 0.070 |
Why?
|
Mice, Knockout | 2 | 2019 | 14471 | 0.060 |
Why?
|
Flow Cytometry | 1 | 2016 | 5890 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 2 | 2016 | 4522 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3425 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2014 | 2426 | 0.060 |
Why?
|
Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2024 | 30 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2020 | 12791 | 0.060 |
Why?
|
Chronic Disease | 1 | 2020 | 9357 | 0.060 |
Why?
|
Rats | 2 | 2019 | 23717 | 0.060 |
Why?
|
DNA Repair | 1 | 2014 | 2050 | 0.060 |
Why?
|
Transcription Factors | 1 | 2024 | 12150 | 0.060 |
Why?
|
Organ Transplantation | 1 | 2015 | 1172 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 11920 | 0.060 |
Why?
|
Antihypertensive Agents | 1 | 2014 | 2030 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2019 | 22248 | 0.060 |
Why?
|
Models, Biological | 1 | 2020 | 9461 | 0.060 |
Why?
|
Cell Cycle | 1 | 2012 | 2926 | 0.060 |
Why?
|
Apoptosis | 3 | 2017 | 9513 | 0.050 |
Why?
|
Cell Proliferation | 3 | 2016 | 10445 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2012 | 2456 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2023 | 26389 | 0.050 |
Why?
|
Transforming Growth Factors | 1 | 2023 | 76 | 0.050 |
Why?
|
Receptors, Neurokinin-1 | 1 | 2023 | 133 | 0.050 |
Why?
|
Myofibroblasts | 1 | 2024 | 230 | 0.050 |
Why?
|
Cecum | 1 | 2023 | 231 | 0.050 |
Why?
|
Hirudins | 1 | 2023 | 179 | 0.050 |
Why?
|
Immunoglobulin G | 1 | 2014 | 4559 | 0.050 |
Why?
|
Trans-Activators | 1 | 2012 | 2855 | 0.050 |
Why?
|
Substance P | 1 | 2023 | 331 | 0.050 |
Why?
|
Endothelium, Vascular | 4 | 2016 | 4424 | 0.050 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2023 | 193 | 0.050 |
Why?
|
Tomography, Optical Coherence | 1 | 2015 | 2937 | 0.050 |
Why?
|
Graft Rejection | 1 | 2015 | 4504 | 0.050 |
Why?
|
Janus Kinase 2 | 1 | 2024 | 562 | 0.050 |
Why?
|
Ubiquitins | 1 | 2023 | 365 | 0.050 |
Why?
|
Thrombin | 1 | 2023 | 600 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2014 | 4924 | 0.050 |
Why?
|
Inflammation | 1 | 2021 | 10860 | 0.050 |
Why?
|
Interleukin-4 | 1 | 2024 | 1155 | 0.040 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2023 | 327 | 0.040 |
Why?
|
Genes, Reporter | 2 | 2016 | 1525 | 0.040 |
Why?
|
Adolescent | 3 | 2019 | 88904 | 0.040 |
Why?
|
Middle Aged | 6 | 2019 | 223257 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9525 | 0.040 |
Why?
|
Female | 11 | 2019 | 396520 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5795 | 0.040 |
Why?
|
Adult | 5 | 2019 | 223307 | 0.040 |
Why?
|
Male | 9 | 2019 | 364142 | 0.040 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 149 | 0.040 |
Why?
|
Child | 2 | 2019 | 80668 | 0.040 |
Why?
|
Pluripotent Stem Cells | 1 | 2024 | 808 | 0.040 |
Why?
|
Cell Adhesion | 2 | 2015 | 3093 | 0.040 |
Why?
|
Apolipoproteins E | 1 | 2023 | 1459 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9611 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2023 | 871 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2024 | 1730 | 0.030 |
Why?
|
Clostridium Infections | 1 | 2023 | 563 | 0.030 |
Why?
|
E2F1 Transcription Factor | 1 | 2016 | 182 | 0.030 |
Why?
|
Hyaluronic Acid | 1 | 2019 | 484 | 0.030 |
Why?
|
Cell Line, Tumor | 1 | 2012 | 17088 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2015 | 6222 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2023 | 1889 | 0.030 |
Why?
|
Anticoagulants | 2 | 2023 | 4855 | 0.030 |
Why?
|
Phosphorylation | 2 | 2016 | 8307 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2016 | 432 | 0.030 |
Why?
|
Leukocyte Elastase | 1 | 2015 | 113 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2023 | 2078 | 0.030 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2015 | 258 | 0.030 |
Why?
|
Arachidonate 5-Lipoxygenase | 1 | 2014 | 128 | 0.030 |
Why?
|
Glutathione Peroxidase | 1 | 2014 | 258 | 0.030 |
Why?
|
Glycerophosphates | 1 | 2013 | 51 | 0.030 |
Why?
|
Complement C3 | 1 | 2015 | 434 | 0.030 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2015 | 591 | 0.030 |
Why?
|
Osteocalcin | 1 | 2013 | 271 | 0.030 |
Why?
|
Mutation | 2 | 2014 | 30213 | 0.030 |
Why?
|
Gene Expression | 2 | 2016 | 7585 | 0.020 |
Why?
|
COS Cells | 1 | 2014 | 1135 | 0.020 |
Why?
|
Chemotaxis | 1 | 2015 | 598 | 0.020 |
Why?
|
HIV | 1 | 2019 | 1588 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3804 | 0.020 |
Why?
|
Aspergillosis | 1 | 2013 | 242 | 0.020 |
Why?
|
Protease Inhibitors | 1 | 2015 | 750 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2023 | 5143 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 1331 | 0.020 |
Why?
|
Oligonucleotides, Antisense | 1 | 2013 | 462 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2014 | 1742 | 0.020 |
Why?
|
Perfusion | 1 | 2015 | 1409 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2014 | 1168 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2013 | 1478 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2016 | 1749 | 0.020 |
Why?
|
Neoplasms | 1 | 2018 | 22350 | 0.020 |
Why?
|
Respiratory Mucosa | 1 | 2012 | 437 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2017 | 2142 | 0.020 |
Why?
|
Autophagy | 1 | 2017 | 1346 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2016 | 1512 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2014 | 2221 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2016 | 1964 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2016 | 2730 | 0.020 |
Why?
|
BRCA1 Protein | 1 | 2014 | 1155 | 0.020 |
Why?
|
RNA Interference | 1 | 2016 | 2827 | 0.020 |
Why?
|
Down-Regulation | 1 | 2014 | 2931 | 0.020 |
Why?
|
Gene Silencing | 1 | 2013 | 1504 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8507 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2014 | 2590 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11061 | 0.020 |
Why?
|
Swine | 1 | 2015 | 5987 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6307 | 0.010 |
Why?
|
Host-Pathogen Interactions | 1 | 2013 | 1466 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5789 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7841 | 0.010 |
Why?
|
DNA Damage | 1 | 2014 | 2467 | 0.010 |
Why?
|
Pyrazoles | 1 | 2014 | 2030 | 0.010 |
Why?
|
Graft Survival | 1 | 2015 | 3904 | 0.010 |
Why?
|
Radiography | 1 | 2015 | 6968 | 0.010 |
Why?
|
Aged | 2 | 2018 | 171343 | 0.010 |
Why?
|
Wound Healing | 1 | 2015 | 2800 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12534 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2014 | 3139 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4780 | 0.010 |
Why?
|
Pyridines | 1 | 2014 | 2888 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 8066 | 0.010 |
Why?
|
Cell Survival | 1 | 2012 | 5748 | 0.010 |
Why?
|
Chromatin | 1 | 2014 | 2977 | 0.010 |
Why?
|
Genetic Testing | 1 | 2014 | 3591 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14652 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5690 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15416 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10264 | 0.010 |
Why?
|
Disease Progression | 1 | 2014 | 13640 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 24295 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 18075 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 59939 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 74881 | 0.010 |
Why?
|